GLP-1s powering Hims & Hers Health, Ro sales growth in 2024 Weight loss sales by direct-to-consumer telehealth firms Hims & Hers Health and Ro grew 112% and 213% since their respective launch months, according to Earnest credit card spending
Underlying medical conditions: Certain conditions can blunt weight loss responses, including hypothyroidism (a thyroid function test is advisable if not recently checked), Cushing's syndrome or exogenous corticosteroid use, polycystic ovary syndrome (PCOS), and obstructive sleep apnoea (OSA)
Eli Lilly's size and dominant position allow it to develop multiple GLP-1 medicines and to expand rapidly into many corners of the world
Some apps even provide unique features for GLP-1 users, such as dosage tracking and weight-loss progress sheets
The agencys September budget request to the governors office attributed the increased use of expensive weight-loss meds with brand names like Wegovy, Zepbound and Saxenda to an explosive rise in demand
Detailed management strategies appear in the semaglutide constipation treatment and tirzepatide constipation treatment guides